Cargando cotizaciones...
Previsión
| Comprar |
1 |
| Mantener |
0 |
| Vender |
0 |
Noticias Ir al feed de noticias
Dominari Holdings changes terms for Series A warrants and offers reduced exercise price
Dominari Holdings agreed incentive arrangements with holders of Series A warrants and is offering two options: exercise all warrants by September 11, 2026 at a reduced price of $2.20 per share, or exchange unexercised warrants for common shares at a ratio of 1 share for every 5 underlying warrants. If holders choose option A, the company expects gross proceeds of about $2.9 million; under option B approximately 115,000 exchange shares would be issued. After the transactions, about 1.2 million Series A warrants would likely remain outstanding; the potential shares are registered for resale in an effective registration statement, while exchange shares are subject to an exemption. » Más en de.investing.com
Dominari Holdings: stock rose by around 400% in 2025, strong capital-markets activity
Dominari Holdings recorded a price gain of about 400% in 2025 (from roughly $1.00 to almost $5.00) and is currently trading at approximately $4.19. The company paid dividends of around $22.2 million in 2025, generated revenue of $99.59 million (+691% YoY) and shows a very low P/E ratio of 0.46 and a price‑to‑book of 0.32. Dominari Securities completed numerous transactions, raised nearly $2 billion in capital (including leading roles in issuances) and strengthened liquidity with a current ratio of 4.74, indicating robust financial metrics and further upside potential. » Más en de.investing.com
Dominari Holdings announces $10 million special dividend
Dominari Holdings will pay a cash special dividend of about $10 million (approximately $0.44 per share), payable around January 23, 2026 to shareholders of record at the close of trading on December 31, 2025. The micro‑cap company, with a market capitalization of roughly $67 million, is unusually issuing a special dividend for the first time despite the stock’s strong rise in 2025. Dominari reports a solid liquidity position (current ratio 4.74) and held about $176.2 million in cash and marketable securities as of September 30, 2025; a previously filed $2 billion shelf registration was withdrawn. Tim Ledwick was also appointed CFO, and the company is pursuing growth opportunities in areas such as AI and data centers. » Más en de.investing.com
Dividendos históricos Dividendos
Todas las métricas de dividendos Todas las métricasDatos financieros de la empresa
| (EUR) | junio de 2026 | YoY |
|---|---|---|
| Ingresos | 14,71 M | 49,15 % |
| Beneficio bruto | 14,71 M | 49,15 % |
| Beneficio neto | -4,36 M | 130,96 % |
| EBITDA | -2,05 M | 87,45 % |
Datos fundamentales
| Métrica | Valor |
|---|---|
Capitalización bursátil | 37,38 M € |
Número de acciones | 24,24 M |
Máximo/mínimo de 52 semanas | 5,48 € - 1,53 € |
Rentabilidad por dividendo | 65,36 % |
Dividendos TTM | 1,01 € |
Beta | 0,88 |
Ratio P/E | -0,49 |
Ratio PEG | 0,00 |
Ratio P/B | 1,80 |
Ratio P/S | 0,31 |
Perfil de la empresa
Dominari Holdings Inc., una empresa de biotecnología, se centra en el desarrollo de terapias antitumorales de molécula pequeña. La cartera de terapias de la compañía incluye tratamientos para el cáncer de próstata, el cáncer de páncreas, la leucemia mieloide aguda (LMA) y la leucemia linfoblástica aguda. Está desarrollando DHA-dFdC, un candidato a fármaco para el cáncer de páncreas, y KPC34, un tratamiento de molécula pequeña para la leucemia mieloide aguda y la leucemia linfoblástica aguda. La compañía también está desarrollando una plataforma antiviral que inhibe la replicación de virus, incluidos el virus de la gripe, el ébolavirus y el virus de Marburgo, SARS-CoV, MERS-CoV y SARS-CoV-2. Tiene acuerdos de licencia con la Universidad de Texas, la Universidad de Maryland en Baltimore, Silo Pharma Inc. y Wake Forest University Health Sciences. La compañía era anteriormente conocida como AIkido Pharma Inc. y cambió su nombre a Dominari Holdings Inc. en diciembre de 2022. Dominari Holdings Inc. fue fundada en 1967 y tiene su sede en Nueva York, Nueva York.
| Nombre | Dominari Holdings |
| CEO | Anthony C. Hayes |
| Sede | New York City,
ny Estados Unidos |
| Sitio web | |
| Sector | Finanzas |
| Industria | Servicios financieros |
| Salida a bolsa | 18/03/1980 |
| Empleados | 36 |
Deep Dive
Símbolos bursátiles
| Bolsa | Símbolo |
|---|---|
NASDAQ | DOMH |
Frankfurt | BP2A.F |
Düsseldorf | BP2A.DU |